{"corpus_id":233322234,"paper_sha":"8e8bcc1c724ba0d1a9f6ebdc01840cccd3409f05","doi":"10.5114/AOMS/132492","arxiv_id":null,"pmid":34522254,"pmcid":"8425263","mag_id":3134314288,"dblp_id":null,"acl_id":null,"title":"Efficacy and harms of convalescent plasma for treatment of hospitalized COVID-19 patients: a systematic review and meta-analysis","year":2021,"publication_date":"2021-02-18","venue":"Archives of medical science : AMS","journal":{"name":"Archives of Medical Science : AMS","pages":"1251 - 1261","volume":"17"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle","Review"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Medicine"],"reference_count":40,"citation_count":8,"influential_citation_count":0,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":null,"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://www.archivesofmedicalscience.com/pdf-132492-67989?filename=Efficacy and harms of.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/8e8bcc1c724ba0d1a9f6ebdc01840cccd3409f05","s2_open_access_license":"CCBYNCSA","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Introduction We systematically reviewed benefits and harms of convalescent plasma (CP) in hospitalized COVID-19 patients. Material and methods Randomized controlled trials (RCTs) and observational studies assessing CP effects on hospitalized, adult COVID-19 patients were searched until November 24, 2020. We assessed risk of bias (RoB) using Cochrane RoB 2.0 and ROBINS-I tools. Inverse variance random effect meta-analyses were performed. Quality of evidence was evaluated using GRADE methodology. Primary outcomes were all-cause mortality, clinical improvement, and adverse events. Results Five RCTs (n = 1067) and 6 cohorts (n = 881) were included. Three and 1 RCTs had some concerns and high RoB, respectively; and there was serious RoB in all cohorts. Convalescent plasma did not reduce all-cause mortality in RCTs of severe (RR = 0.60, 95% CI: 0.33–1.10) or moderate (RR = 0.60, 95% CI: 0.09–3.86) COVID-19 vs. standard of care (SOC); CP reduced all-cause mortality vs. SOC in cohorts (RR = 0.66, 95% CI: 0.49–0.91). Convalescent plasma did not reduce invasive ventilation vs. SOC in moderate disease (RR = 0.85, 95% CI: 0.47–1.55). In comparison to placebo + SOC, CP did not affect all-cause mortality (RR = 0.75, 95% CI: 0.48–1.16) or clinical improvement (HR = 1.07, 95% CI: 0.82–1.40) in severe patients. Adverse and serious adverse events were scarce, similar between CP and controls. Quality of evidence was low or very low for most outcomes. Conclusions In comparison to SOC or placebo + SOC, CP did not reduce all-cause mortality in RCTs of hospitalized COVID-19 patients. Convalescent plasma did not have an effect on other clinical or safety outcomes. Until now there is no good quality evidence to recommend CP for hospitalized COVID-19 patients.","claims":[{"public_id":"cl_bcd2f4b0419592d1800e1c52e40daae0","status":"active","text":"Adverse and serious adverse events were scarce and similar between convalescent plasma and controls.","confidence":0.85,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_bcd2f4b0419592d1800e1c52e40daae0"},{"public_id":"cl_45edf6f5c183e058ef1c48777ca7f279","status":"active","text":"Convalescent plasma did not reduce all-cause mortality in RCTs of severe COVID-19 (RR = 0.60, 95% CI: 0.33–1.10) or moderate COVID-19 (RR = 0.60, 95% CI: 0.09–3.86) vs. standard of care.","confidence":0.95,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_45edf6f5c183e058ef1c48777ca7f279"},{"public_id":"cl_6765b204afbcb75d471c36409f81c2d6","status":"active","text":"Convalescent plasma did not reduce invasive ventilation vs. standard of care in moderate disease (RR = 0.85, 95% CI: 0.47–1.55).","confidence":0.9,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_6765b204afbcb75d471c36409f81c2d6"},{"public_id":"cl_e7f5ff8e9d146cfa54200fae7bfa8d05","status":"active","text":"Convalescent plasma reduced all-cause mortality vs. standard of care in cohort studies (RR = 0.66, 95% CI: 0.49–0.91).","confidence":0.9,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_e7f5ff8e9d146cfa54200fae7bfa8d05"},{"public_id":"cl_12ffb40d9f9c4ec0c3169453117464e8","status":"active","text":"In comparison to placebo plus standard of care, convalescent plasma did not affect all-cause mortality (RR = 0.75, 95% CI: 0.48–1.16) or clinical improvement (HR = 1.07, 95% CI: 0.82–1.40) in severe patients.","confidence":0.95,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_12ffb40d9f9c4ec0c3169453117464e8"}],"concepts":[{"public_id":"co_02bb68bfb7091294c01d228de4542751","status":"active","name":"severe COVID-19","description":"Hospitalized COVID-19 patients with severe disease, as classified in the included studies.","types":["patient subgroup"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_02bb68bfb7091294c01d228de4542751"},{"public_id":"co_052a169681b5c9e0e158f2084c68499d","status":"active","name":"serious adverse events","description":"Adverse events that result in death, life-threatening condition, hospitalization, or significant disability, compared between groups.","types":["outcome"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_052a169681b5c9e0e158f2084c68499d"},{"public_id":"co_2693154591cac35810f6058d03698c1b","status":"active","name":"convalescent plasma","description":"Plasma collected from recovered COVID-19 patients, used as an experimental treatment for hospitalized COVID-19 patients.","types":["therapeutic intervention"],"aliases":["CP"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_2693154591cac35810f6058d03698c1b"},{"public_id":"co_2cee9f4e22f15418a04b5bcc39e4be10","status":"active","name":"moderate COVID-19","description":"Hospitalized COVID-19 patients with moderate disease, as classified in the included studies.","types":["patient subgroup"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_2cee9f4e22f15418a04b5bcc39e4be10"},{"public_id":"co_590d45c65c1d9995f4400725bfe25649","status":"active","name":"placebo plus standard of care","description":"Control arm receiving placebo (e.g., saline) plus standard of care, used in some RCTs.","types":["control condition"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_590d45c65c1d9995f4400725bfe25649"},{"public_id":"co_5f4198eda7aa181edf806ed474f967b9","status":"active","name":"invasive ventilation","description":"Mechanical ventilation via endotracheal tube or tracheostomy, assessed as an outcome in moderate COVID-19 patients.","types":["outcome"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5f4198eda7aa181edf806ed474f967b9"},{"public_id":"co_615627f22798b68884c7ca94a27f8a0f","status":"active","name":"all-cause mortality","description":"Death from any cause, used as a primary outcome in the meta-analysis.","types":["outcome"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_615627f22798b68884c7ca94a27f8a0f"},{"public_id":"co_63199c12cf684a3f80d68459122e0bf4","status":"active","name":"cohort studies","description":"Observational studies comparing patients who received convalescent plasma with those who did not, included in the review.","types":["study design"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_63199c12cf684a3f80d68459122e0bf4"},{"public_id":"co_98d87c5b1890a7cc089c8d84b86b9a2b","status":"active","name":"randomized controlled trials","description":"Studies in which patients were randomly assigned to convalescent plasma or control, included in the review.","types":["study design"],"aliases":["RCTs"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_98d87c5b1890a7cc089c8d84b86b9a2b"},{"public_id":"co_b5e79e68d33ad1cc994c6b3d8aeb3781","status":"active","name":"adverse events","description":"Any untoward medical occurrence in patients, compared between convalescent plasma and control groups.","types":["outcome"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b5e79e68d33ad1cc994c6b3d8aeb3781"},{"public_id":"co_dd44ed71f49003c8cbffe66d194eb02a","status":"active","name":"standard of care","description":"The control treatment consisting of usual clinical care without convalescent plasma.","types":["control condition"],"aliases":["SOC"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_dd44ed71f49003c8cbffe66d194eb02a"},{"public_id":"co_f3e4c6cf6cd5c1d7276e53b5cb70c663","status":"active","name":"clinical improvement","description":"Improvement in clinical status, measured as a time-to-event outcome in severe patients.","types":["outcome"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f3e4c6cf6cd5c1d7276e53b5cb70c663"}],"external_ids":{"DOI":"10.5114/AOMS/132492","ArXiv":null,"PubMed":34522254,"PubMedCentral":"8425263","MAG":3134314288,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://www.archivesofmedicalscience.com/pdf-132492-67989?filename=Efficacy and harms of.pdf","landing_url":"https://www.semanticscholar.org/paper/8e8bcc1c724ba0d1a9f6ebdc01840cccd3409f05","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNCSA","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":637640,"paper_uid":"8f8b8c67-fd3a-4d58-aacf-2310db6bcd8f","canonical_identity":{"paper_id":637640,"paper_uid":"8f8b8c67-fd3a-4d58-aacf-2310db6bcd8f","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/233322234"}